These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. The Evolving Evidence for Therapeutic Drug Monitoring of Monoclonal Antibodies in Inflammatory Bowel Disease. Sheasgreen C; Nguyen GC Curr Gastroenterol Rep; 2017 May; 19(5):19. PubMed ID: 28397129 [TBL] [Abstract][Full Text] [Related]
50. The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection. Singh R; Nieuwdorp M; ten Berge IJ; Bemelman FJ; Geerlings SE Clin Microbiol Infect; 2014 Nov; 20(11):1119-25. PubMed ID: 25274035 [TBL] [Abstract][Full Text] [Related]
51. Nanotechnology in the Treatment of Inflammatory Bowel Disease. Giron F; Pastó A; Tasciotti E; Abraham BP Inflamm Bowel Dis; 2019 Nov; 25(12):1871-1880. PubMed ID: 31560054 [TBL] [Abstract][Full Text] [Related]
53. [Croatian consensus on the treatment of inflammatory bowel diseases with biologic therapy]. Vucelić B; Cuković-Cavka S; Banić M; Bilić A; Borzan V; Duvnjak M; Katicić M; Kolacek S; Krznarić Z; Kujundzić M; Marusić M; Mihaljević S; Mijandrusić BS; Persić M; Simunić M; Skurla B; Stimac D; Tonkić A; Troskot B Acta Med Croatica; 2013 Apr; 67(2):75-87. PubMed ID: 24471291 [TBL] [Abstract][Full Text] [Related]
54. Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data. Long GH; Tatro AR; Oh YS; Reddy SR; Ananthakrishnan AN Adv Ther; 2019 Nov; 36(11):3079-3095. PubMed ID: 31562607 [TBL] [Abstract][Full Text] [Related]
55. Discussion on the biologic therapy of inflammatory bowel disease. Merger M; Herfarth H; Scholmerich J; Andus T; Färber L Gastroenterology; 2003 Jun; 124(7):2005-6. PubMed ID: 12812200 [No Abstract] [Full Text] [Related]
56. [Place of biologic therapy in the treatment of inflammatory bowel diseases and assessment of its efficacy]. Krznarić Z; Stimac D; Franjić N; Kunović A; Kelecić DL Acta Med Croatica; 2013 Apr; 67(2):145-55. PubMed ID: 24471297 [TBL] [Abstract][Full Text] [Related]
57. [Inflammatory bowel disease during pregnancy and childbirth]. Závorová K Ceska Gynekol; 2017; 82(2):108-116. PubMed ID: 28585842 [TBL] [Abstract][Full Text] [Related]
58. [Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature]. Beniada A; Benoist G; Maurel J; Dreyfus M J Gynecol Obstet Biol Reprod (Paris); 2005 Oct; 34(6):581-8. PubMed ID: 16208201 [TBL] [Abstract][Full Text] [Related]
59. Modulation of sphingosine-1-phosphate in inflammatory bowel disease. Peyrin-Biroulet L; Christopher R; Behan D; Lassen C Autoimmun Rev; 2017 May; 16(5):495-503. PubMed ID: 28279838 [TBL] [Abstract][Full Text] [Related]
60. The risks and benefits of early immunosuppression and biological therapy. Sands BE Dig Dis; 2012; 30 Suppl 3():100-6. PubMed ID: 23295699 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]